首页> 美国卫生研究院文献>BMC Gastroenterology >Ten-day bismuth-containing quadruple therapy versus 7-day proton pump inhibitor-clarithromycin containing triple therapy as first-line empirical therapy for the

【2h】

Ten-day bismuth-containing quadruple therapy versus 7-day proton pump inhibitor-clarithromycin containing triple therapy as first-line empirical therapy for the

机译：含有十天的铋四重治疗与7天质子泵抑制剂 - 含Clarithromycin含有三重疗法作为一线实证疗法

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

The online version contains supplementary material available at 10.1186/s12876-021-01680-1.

机译：在线版本包含10.1186 / S12876-021-01680-1可用的补充材料。

著录项

期刊名称 BMC Gastroenterology
作者
Young-Il Kim; Jong Yeul Lee; Chan Gyoo Kim; Boram Park; Jin Young Park; Il Ju Choi;
展开▼
作者单位

展开▼
年(卷),期 2021(-1),-1
年度 2021
页码 -1
总页数 10
原文格式 PDF
正文语种
中图分类肠道病毒与肝炎病毒;肝及胆疾病;肠疾病;
关键词
Helicobacter pylori;

机译：幽门螺杆菌;

相似文献

外文文献
中文文献
专利

1. Ten-day bismuth-containing quadruple therapy versus 7-day proton pump inhibitor-clarithromycin containing triple therapy as first-line empirical therapy for the Helicobacter pylori infection in Korea: a randomized open-label trial [J] . Young-Il Kim, Jong Yeul Lee, Chan Gyoo Kim, BMC Gastroenterology . 2021,第1期

机译：含有十天的铋四肢疗法与7天质子泵抑制剂 - 含有三重疗法的三分比霉素作为韩国幽门螺杆菌感染的一线实证治疗：随机开放标签试验
2. Efficacy of 7-Day and 14-Day Bismuth-Containing Quadruple Therapy and 7-Day and 14-Day Moxifloxacin-Based Triple Therapy as Second-Line Eradication for Helicobacter pylori Infection [J] . Seong tae Lee Dong Ho Lee Ji Hyun Lim Nayoung Kim Young Soo Park Cheol Min Shin Hyun Jin Jo, In sung Song Gut and Liver . 2015,第4期

机译：7天和14天含铋四联疗法和7天和14天基于莫西沙星的三联疗法作为根除幽门螺杆菌感染的第二线疗效
3. Ten-day bismuth-containing quadruple therapy is effective as first-line therapy for Helicobacter pylori-related chronic gastritis: a prospective randomized study in China [J] . Wang L., Lin Z., Chen S., Clinical microbiology and infection: European Society of Clinical Microbiology and Infectious Diseases . 2017,第6期

机译：含有十天的铋四重治疗是幽门螺杆菌相关慢性胃炎的一线治疗有效：中国的前瞻性随机研究
4. Is High-Dose Chemotherapy Plus Stem-Cell Transplant the Standard Treatment for Patients Failing First-Line Chemotherapy for Metastatic Germ Cell Tumor? [C] . Christian Kollmannsberger, Lawrence Einhorn, Craig Nichols Genitourinary Cancers Symposium. . 2014

机译：高剂量化疗加干细胞移植对转移细胞肿瘤的一线化疗失败的患者的标准治疗吗？
5. Modeling secondary cancer risk following paediatric radiotherapy: a comparison of intensity modulated proton therapy and photon therapy. [D] . Shin, Naomi. 2012

机译：儿科放射治疗后的继发性癌症风险建模：强度调制质子治疗与光子治疗的比较。
6. Efficacy of 7-Day and 14-Day Bismuth-Containing Quadruple Therapy and 7-Day and 14-Day Moxifloxacin-Based Triple Therapy as Second-Line Eradication for Helicobacter pylori Infection [O] . Seong tae Lee, Dong Ho Lee, Ji Hyun Lim, 2019

机译：7天和14天含铋四联疗法和7天和14天莫西沙星为基础的三联疗法根除幽门螺杆菌感染的疗效
7. Modified quadruple therapy versus bismuth-containing quadruple therapy in first-line treatment of Helicobacter pylori infection in Korea; rationale and design of an open-label, multicenter, randomized controlled trial [O] . Hyun Lim, Chang Seok Bang, Woon Geon Shin, 2018

机译：改良的四重治疗与含有铋的四重疗法在韩国幽门螺杆菌感染的一线治疗中;开放标签，多中心，随机对照试验的理由和设计

Ten-day bismuth-containing quadruple therapy versus 7-day proton pump inhibitor-clarithromycin containing triple therapy as first-line empirical therapy for the

摘要

著录项

相似文献

相关主题

期刊订阅